These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23073045)

  • 41. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
    Kjaersgaard M; Edslev PW; Rosthøj S
    Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatigue in children and adolescents with immune thrombocytopenia.
    Grace RF; Klaassen RJ; Shimano KA; Lambert MP; Grimes A; Bussel JB; Breakey VR; Pastore YD; Black V; Overholt K; Bhat R; Forbes PW; Neunert C
    Br J Haematol; 2020 Oct; 191(1):98-106. PubMed ID: 32501532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current challenges in the management of children with idiopathic thrombocytopenic purpura.
    Buchanan GR; Adix L
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):681-4. PubMed ID: 16933253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Idiopathic thrombocytopenic purpura.
    Palaniappan G; Jennings W
    Mo Med; 2009; 106(1):69-73. PubMed ID: 19245128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the impact and burden of illness of adult chronic ITP in the US.
    Saleh MN; Fisher M; Grotzinger KM
    Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term follow-up of chronic idiopathic thrombocytopenic purpura in children].
    Amendola G; Danise P; D'Arco A
    Pediatr Med Chir; 2000; 22(1):39-41. PubMed ID: 11387765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
    Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
    Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
    McMillan R
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
    Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
    Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy.
    Andersson PO; Wadenvik H
    Expert Rev Mol Med; 2004 Nov; 6(24):1-17. PubMed ID: 15538954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.
    Lowe EJ; Buchanan GR
    J Pediatr; 2002 Aug; 141(2):253-8. PubMed ID: 12183723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controversies in the diagnosis and management of childhood acute immune thrombocytopenic purpura.
    Segel GB; Feig SA
    Pediatr Blood Cancer; 2009 Sep; 53(3):318-24. PubMed ID: 19165890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Refractory idiopathic thrombocytopenic purpura].
    Iki S; Urabe A
    Nihon Rinsho; 2003 Apr; 61(4):609-14. PubMed ID: 12718084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].
    Le Meignen M; Mossler P; Mates M; Mathey C; Hass A; Monpoux F; Faverge B; Fortier G; Nguyen J; Belahbib L; Coache C; Chamoulli JM; Moulène E; Sirvent N; Michel G; Chambost H
    Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bleeding severity as an important outcome in childhood immune thrombocytopenia.
    Flores A; Buchanan GR
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S8-11. PubMed ID: 23109508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis.
    Buchanan GR; Journeycake JM; Adix L
    Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).
    Imbach P; Kühne T; Müller D; Berchtold W; Zimmerman S; Elalfy M; Buchanan GR
    Pediatr Blood Cancer; 2006 Mar; 46(3):351-6. PubMed ID: 16086422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of immune thrombocytopenic purpura in adults.
    Stasi R; Provan D
    Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of patients with refractory immune thrombocytopenic purpura.
    George JN
    J Thromb Haemost; 2006 Aug; 4(8):1664-72. PubMed ID: 16879206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.